Fred M. Teskin

Array ( [id] => 12158864 [patent_doc_number] => 20180030130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'METHOD OF TREATING A LOCALIZED FIBROTIC DISORDER USING AN IL-33 ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 15/555027 [patent_app_country] => US [patent_app_date] => 2016-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 12778 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14762103 [patent_doc_number] => 10392436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-27 [patent_title] => Anti-human IL-17 monoclonal antibodies and use thereof [patent_app_type] => utility [patent_app_number] => 15/510655 [patent_app_country] => US [patent_app_date] => 2016-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 10160 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16305369 [patent_doc_number] => 10774148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-15 [patent_title] => Composition for treating IL-6-related diseases [patent_app_type] => utility [patent_app_number] => 15/553609 [patent_app_country] => US [patent_app_date] => 2016-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12070 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11038883 [patent_doc_number] => 20160235840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'Compositions, Comprising Improved Il-12 Genetic Constructs And Vaccines, Immunotherapeutics And Methods Of Using The Same' [patent_app_type] => utility [patent_app_number] => 15/055002 [patent_app_country] => US [patent_app_date] => 2016-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16102 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15055002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11129265 [patent_doc_number] => 20160326241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-10 [patent_title] => 'TNFA-IL-17 BISPECIFIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 15/012499 [patent_app_country] => US [patent_app_date] => 2016-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 22470 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11092350 [patent_doc_number] => 20160289319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-06 [patent_title] => 'ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMA' [patent_app_type] => utility [patent_app_number] => 15/010900 [patent_app_country] => US [patent_app_date] => 2016-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18840 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15010900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12127524 [patent_doc_number] => 20180011110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'Methods and Compositions in Diagnosis of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis' [patent_app_type] => utility [patent_app_number] => 15/543943 [patent_app_country] => US [patent_app_date] => 2016-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20019 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15543943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14422629 [patent_doc_number] => 10316104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-11 [patent_title] => Immunoconjugates [patent_app_type] => utility [patent_app_number] => 14/996893 [patent_app_country] => US [patent_app_date] => 2016-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 112 [patent_no_of_words] => 48672 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14996893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13328583 [patent_doc_number] => 20180215829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => ANTI-IL-17RA IMMUNOGLOBULIN SINGLE HEAVY VARIABLE DOMAIN ANTIBODIES [patent_app_type] => utility [patent_app_number] => 15/541876 [patent_app_country] => US [patent_app_date] => 2016-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39603 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12680962 [patent_doc_number] => 20180118820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => IL-17A BINDING PROTEINS [patent_app_type] => utility [patent_app_number] => 15/541889 [patent_app_country] => US [patent_app_date] => 2016-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39819 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11323830 [patent_doc_number] => 20160354442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'THERAPEUTIC METHOD OF INDUCING MITOCHONDRIAL BIOGENESIS TO TREAT SKIN AND MUSCLE PATHOLOGIES' [patent_app_type] => utility [patent_app_number] => 14/992969 [patent_app_country] => US [patent_app_date] => 2016-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 8488 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14992969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11324974 [patent_doc_number] => 20160355585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'ANTAGONISTS OF IL-6 TO RAISE ALBUMIN AND/OR LOWER CRP' [patent_app_type] => utility [patent_app_number] => 14/988337 [patent_app_country] => US [patent_app_date] => 2016-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 109890 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 79 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11324974 [patent_doc_number] => 20160355585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'ANTAGONISTS OF IL-6 TO RAISE ALBUMIN AND/OR LOWER CRP' [patent_app_type] => utility [patent_app_number] => 14/988337 [patent_app_country] => US [patent_app_date] => 2016-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 109890 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 79 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11324974 [patent_doc_number] => 20160355585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'ANTAGONISTS OF IL-6 TO RAISE ALBUMIN AND/OR LOWER CRP' [patent_app_type] => utility [patent_app_number] => 14/988337 [patent_app_country] => US [patent_app_date] => 2016-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 109890 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 79 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11324974 [patent_doc_number] => 20160355585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'ANTAGONISTS OF IL-6 TO RAISE ALBUMIN AND/OR LOWER CRP' [patent_app_type] => utility [patent_app_number] => 14/988337 [patent_app_country] => US [patent_app_date] => 2016-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 109890 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 79 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13049301 [patent_doc_number] => 10046027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-14 [patent_title] => Muteins of tear lipocalin and methods for obtaining the same [patent_app_type] => utility [patent_app_number] => 14/981589 [patent_app_country] => US [patent_app_date] => 2015-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 51 [patent_no_of_words] => 32427 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14981589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10996367 [patent_doc_number] => 20160193313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA' [patent_app_type] => utility [patent_app_number] => 14/972865 [patent_app_country] => US [patent_app_date] => 2015-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15612 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14972865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14791539 [patent_doc_number] => 10398755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-03 [patent_title] => Clusterin pharmaceuticals and treatment methods using the same [patent_app_type] => utility [patent_app_number] => 14/971862 [patent_app_country] => US [patent_app_date] => 2015-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15158 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14971862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12837511 [patent_doc_number] => 20180171010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => COMPOSITION, KIT AND METHOD FOR INHIBITION OF IL-21 MEDIATED ACTIVATION OF HUMAN CELLS [patent_app_type] => utility [patent_app_number] => 15/537566 [patent_app_country] => US [patent_app_date] => 2015-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8403 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15537566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12979828 [patent_doc_number] => 20170342147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-30 [patent_title] => Antibodies for IL-17C [patent_app_type] => utility [patent_app_number] => 15/535487 [patent_app_country] => US [patent_app_date] => 2015-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24784 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15535487 [rel_patent_id] =>[rel_patent_doc_number] =>)